Evidence map›Paper›PMID 29286435›Full record

ArticleJournal of visualized experiments : JoVE2017

Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device.

Megha Gulati, Craig L Ennis, Diana L Rodriguez, Clarissa J Nobile

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Transcription Factor Stp2 Is Important forFrontiers in microbiology · 2020
    Article
  8. Article
  9. Article
  10. Methodologies forMicrobial cell (Graz, Austria) · 2018
    Review
  11. Synergistic Effect of Quinic Acid Derived FromFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Megha GulatiDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced.
Craig L EnnisDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced.
Diana L RodriguezDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced.
Clarissa J NobileDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced; cnobile@ucmerced.edu.
University of California, Merced · US

Funding

Regulation of Sexual Biofilm Development in Candida albicansR21AI125801 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI NOBILE, CLARISSA JANE · 2017 to 2018
$503k
NIAID NIH HHS R21 AI125801
6 · The paper itself

Abstract

Candida albicans is the most common fungal pathogen of humans, causing about 15% of hospital-acquired sepsis cases. A major virulence attribute of C. albicans is its ability to form biofilms, structured communities of cells attached to biotic and abiotic surfaces. C. albicans biofilms can form on host tissues, such as mucosal layers, and on medical devices, such as catheters, pacemakers, dentures, and joint prostheses. Biofilms pose significant clinical challenges because they are highly resistant to physical and chemical perturbations, and can act as reservoirs to seed disseminated infections. Various in vitro assays have been utilized to study C. albicans biofilm formation, such as microtiter plate assays, dry weight measurements, cell viability assays, and confocal scanning laser microscopy. All of these assays are single end-point assays, where biofilm formation is assessed at a specific time point. Here, we describe a protocol to study biofilm formation in real-time using an automated microfluidic device under laminar flow conditions. This method allows for the observation of biofilm formation as the biofilm develops over time, using customizable conditions that mimic those of the host, such as those encountered in vascular catheters. This protocol can be used to assess the biofilm defects of genetic mutants as well as the inhibitory effects of antimicrobial agents on biofilm development in real-time.

Indexed as

BiofilmsCandida albicansHumansLab-On-A-Chip Devices

Identifiers

PMID29286435
PMCPMC5752124
OpenAlexW2773342946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.